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Abstract
Background: Dietary silicon has been positively linked with vascular health and protection against atherosclerotic plaque
formation, but the mechanism of action is unclear.
Objectives:We investigated the effect of dietary silicon on 1) serum and aorta silicon concentrations, 2) the development
of aortic lesions and serum lipid concentrations, and 3) the structural and biomechanic properties of the aorta.
Methods: Two studies, of the same design, were conducted to address the above objectives. Female mice, lacking the
apolipoprotein E (apoE) gene, and therefore susceptible to atherosclerosis, were separated into 3 groups of 10–15 mice,
each exposed to a high-fat diet (21% wt milk fat and 1.5% wt cholesterol) but with differing concentrations of dietary
silicon, namely: silicon-deprived (2Si; <3-mg silicon/g feed), silicon-replete in feed (+Si-feed; 100-mg silicon/g feed), and
silicon-replete in drinking water (+Si-water; 115-mg silicon/mL) for 15–19 wk. Silicon supplementation was in the form of
sodium metasilicate (feed) or monomethylsilanetriol (drinking water).
Results: The serum silicon concentration in the2Si group was significantly lower than in the +Si-feed (by up to 78%; P <
0.003) and the +Si-water (by up to 84%; P < 0.006) groups. The aorta silicon concentration was also lower in the2Si group
than in the +Si-feed group (by 65%; P = 0.025), but not compared with the +Si-water group. There were no differences in
serum and aorta silicon concentrations between the silicon-replete groups. Bodyweights, tissue wet weights at necropsy,
and structural, biomechanic, and morphologic properties of the aorta were not affected by dietary silicon; nor were the
development of fatty lesions and serum lipid concentrations.
Conclusions: These findings suggest that dietary silicon has no effect on atherosclerosis development and vascular
health in the apoE mouse model of diet-induced atherosclerosis, contrary to the reported findings in the cholesterol-fed
rabbit model. J Nutr 2015;145:1498–506.
Keywords: aortic lesions, aorta silicon content, apoE knockout mice, collagen and elastin contents, dietary silicon,
monomethylsilanetriol, elastic structure and morphology, nutrition, serum lipids, tensile strength and elasticity
Introduction
Silicon, a major trace element of the daily diet (1, 2), may be
important for the normal health of bone and connective tissues
(3–6). This includes vascular tissue, where dietary silicon has
been positively linked with cardiovascular health (7–13).
Schwarz (11) reported an inverse association between silicon
concentrations in drinking water and the number of deaths from
cardiovascular disease in Finland. He proposed that a lack of
silicon in the diet and in drinking water may contribute to the
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etiology of the disease, whereas sufficiency or excess may inhibit
disease development. A similar association was reported by
Dawson et al. (14). Indeed, silicon administered intravenously
or orally to cholesterol-fed rabbits greatly reduced, and almost
negated, the formation of cholesterol plaques (8). Maehira et al.
(12) reported that soluble silica significantly reduced systolic
blood pressure in spontaneously hypertensive rats, suggesting
that silicon may reduce hypertension. Buffoli et al. (13) reported
in a mouse model of physiologic aging that silicon supple-
mentation in drinking water can protect against age-related
vascular aging. These findings suggest a potential role for
dietary silicon in vascular health, although the mechanism of
action is unclear.
High concentrations of silicon are found in normal healthy
connective tissues, including the aorta, where it is associated
with the elastin and collagen components of the aortic wall (8,
15), and concentrations decrease with aging and with the
progression of atherosclerosis (8, 10). Histologic analysis of the
aortic wall of cholesterol-fed rabbits with and without silicon
treatment found that the elastic fibers of the internal elastic
lamina seemed ‘‘undamaged and often thickened’’ in the silicon-
supplemented groups compared with the control group (8).
These findings led to the suggestion that silicon may be an
important structural component of the aortic wall that protects
against lipid permeability (8). A further proposal is that silicon
supplementation decreases the concentrations of FAs that are
negatively linked to atherosclerotic plaque formation in serum
and aorta (7, 9, 16). However, the changes in serum and aorta
lipid concentrations are small, albeit significant, and concentra-
tions are still higher than those of animals on the normal (i.e.,
low-fat) diet (7, 9, 16). Furthermore, neither of these proposed
mechanisms would explain the observed decrease in blood
pressure and hypertension with silicon supplementation (12).
We investigated the effect of dietary silicon on a model of
diet-induced fatty streak lesions in female apoE knockout mice
(C57BL/6J-ApoE/J) fed a diet high in butter fat. We investigated
1) the development of aortic lesions and blood FA concentra-
tions, 2) the main structural components of the aorta (collagen
and elastin concentrations as well as elastic structure and
morphology), and 3) the biomechanic properties of the aorta
(tensile strength and elasticity), to probe potential mechanisms
of action of silicon in vascular health. The overall objective of
the study was to show whether dietary silicon could protect
against atherosclerosis in a model with a strong genetic drive as




The formulated high-fat diets were produced by Dr. Forrest Nielsen
(USDA Grand Forks Human Nutrition Research Center, Grand Forks,
North Dakota). Monomethylsilanetriol (115-mg silicon/mL) was from
LLR-G5 Ltd. (Castlebar, Ireland). Sterile, low-silicon-containing deion-
ized drinking water was from Sigma-Aldrich Co. For sample analysis,
ultra-high purity water was 18 mol/LU/cm, from a Branstead Nano-
Pure water purifier (Thermo Scientific). Ketamine HCL (Ketasol-100)
was from Dr. E Graeub AG, and xylazine (Rompun) was from Bayer
HealthCare AG. Polypropylene tubes (13 mL and 25 mL) and
microvettes (CB 300Z) were from Sarstedt Ltd. Eppendorf tubes
(1.5 mL) were from Eppendorf. PBS was from PAA Laboratories GmbH.
Mice and dietary intervention groups
Female C57BL/6J-ApoE/J mice, referred hereafter as female apoE
knockout mice, were obtained from the Institute of Zoology and
Genetics (Himberg, Austria). Female mice were chosen because previous
studies have shown that the silicon effect is more enhanced in females of
the species, implying that there may be a silicon-estrogen interaction (17,
18). The mice were housed in plastic cages with stainless steel covers, at
22C, with a 12/12-h light/dark cycle and 45% humidity. They were
maintained on R/M-H feed (Sniff) and tap water for 6–8 d to acclimatize
before being randomly divided into 3 groups of mice (n = 9–15 mice/
group). The first group, the silicon-deprived (2Si)9 group, received a
specifically formulated high-fat diet (21% wt anhydrous milk fat and
1.5% wt cholesterol; Supplemental Table 1) with low silicon (<3 mg
silicon/g) as well as low-silicon drinking water (0.04 mg silicon/mL) ad
libitum. The second group was the silicon-replete (+Si) in feed (+Si-feed)
group, which received the same high-fat feed but the feed was replete
in silicon at 100-mg silicon/g feed, as sodium metasilicate. This is
still relatively low in silicon compared to normal murine laboratory
maintenance feed (R/M-H), which was found to contain 669 6 60-mg
silicon/g feed. However, sodium metasilicate is readily bioavailable
unlike much of the silicon naturally present in laboratory rodent diets
(19). Drinking water consisted of the low-silicon water. The third and
final group was the silicon-replete in drinking water (+Si-water) group,
which received the same high-fat, low-silicon feed as group 1, but their
drinking water was replete in silicon at 115 mg silicon/mL in the form
of monomethylsilanetriol [CH3Si(OH)3]. Monomethylsilanetriol was
used in the original study that reported the antiatherosclerotic action of
silicon (8). It is also safe, metabolized in vivo to orthosilicic acid, Si(OH)4 (20,
21), and is a convenient form of soluble silicon for dosing unlike orthosilicic
acid because it does not polymerize at the concentration used here.
Studies 1 and 2
Two studies were conducted. The first study (Study 1) investigated the
effect of the dietary silicon on the formation of fatty streak lesions (early
atherosclerotic plaques). The2Si group consisted of 9 mice, whereas the
+Si groups consisted of 10 mice. Mice were 29 6 13 d (4–6 wk) old at
the start of the intervention. Dietary intervention lasted for 15 wk. One
mouse in the2Si groupwas killed at 11wk, with an overdose of ketamine
hydrochloric acid and xylazine, to check for the development of fatty
streak lesions. This was found to be low, so the remaining mice were
maintained on their respective diets for an additional 4 wk. One mouse in
the 2Si group died during the study (week 8). The cause of death was
unclear, but it is unlikely to be related to the treatment received. This left
only 7 mice in the 2Si group at the end of the study.
The second study (Study 2) investigated the effect of the dietary
silicon on total serum lipids and on the structural and biomechanic
properties of the aorta (tensile strength, elasticity, collagen and elastin
content, and elastin structure and morphology). Groups consisted of 15
mice in the 2Si group and 10 mice in the +Si groups. Mice were 114 6
9 d (16–17 wk) old at the start of the intervention and were maintained
on their respective diets for up to 19 wk.
In both studies, 5 mice were collected before separation into the 3
dietary silicon groups. The ‘‘baseline’’ samples from these mice will
indicate the magnitude of the changes (e.g., in plasma lipid concentra-
tions) caused by the dietary interventions. However, because of the small
numbers, these baseline samples were not compared statistically with the
treatment groups.
Study design
Mice were maintained on their respective diets for up to 19 wk as
detailed above. Their outward appearance was checked every second day
and any differences or abnormalities documented. They were weighed
weekly at 0900 on a precision scale (PAC 3000; Sartorius), accurate
to 0.001 g, after overnight feed deprivation. A blood sample was
collected monthly from the tail vein, again at 0900 after overnight feed
deprivation. Overnight feed deprivation consisted of removing their feed
and drinking water at 1700 (or earlier) the previous day with only access
to deionized water of negligible silicon content throughout the period of
feed deprivation. Feed and water intakes were measured as described
below. At the end of the dietary intervention period, the mice were killed
9 Abbreviations used: 2Si, silicon-deprived; +Si, silicon-replete; +Si-feed,
silicon-replete in feed; +Si-water, silicon-replete in drinking water.
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over a 5-d period to allow time for tissue processing. Equal numbers of
mice from the 3 dietary groups were killed on each day. Before killing,
mice were deprived of food overnight as described above. At 0900 the
following day, they were anesthetized with a mixture of ketamine
hydrochloric acid and xylazine, weighed, the peritoneal cavity opened,
and a blood sample collected from the abdominal vena cava. Thereafter,
mice were immediately killed with an overdose of the ketamine
hydrochloric acid and xylazine mixture, and tissues were collected
into individual pre-weighed 13-mL polypropylene tubes (kidneys,
spleen, liver, lungs, small and large intestines, femurs and tibias, skin,
and ears). The aorta and the heart were then harvested. The whole aorta
(i.e., the ascending, descending, and abdominal aorta), the aortic arch,
and the iliac bifurcation and parts of the common iliac arteries
(Supplemental Figure 1) were removed and cleaned of connective tissue
and fat. The aorta and heart were kept moist with saline throughout the
dissection to avoid dehydration and loss of integrity. The heart was then
separated from the aorta and placed into a pre-weighed 13-mL
polypropylene tube. The aorta was prepared for the analyses as described
below. All excised tissues were weighed in pre-weighed polypropylene
tubes immediately after collection to determine mass (to the nearest
0.001 g) and snap frozen in liquid nitrogen. Samples were stored at
280C until analyses. The studies described here were approved by the
Commission for Animal Testing of the Austrian Ministry for Science and
Research.
Silicon intake
Feed and water intakes were measured at 9 and 11 wk in Study 1 and at
1 and 15 wk in Study 2. The feed tray and plastic water bottle of each
cage were appropriately filled and weighed to the nearest 0.1 g and
0.01 g, respectively, and placed back in the cages. Twenty-four hours
later the feed trays and water bottles were reweighed to measure the
loss in mass because of intakes. The feed trays and water bottles were
refilled and reweighed, and this 24-h measurement was repeated the
following day.
Monthly blood collection
Blood samples were collected monthly from mice in the 3 dietary
silicon groups. Mice were deprived of food overnight and were
warmed with a heating lamp for up to 5 min and their tails for an
additional 2 min before blood collection to ensure good blood flow.
A wound was then created on the tail with a scalpel and blood was
collected with microvettes. A maximum of 500 mL per mouse was
collected.
Preparation of blood samples
Blood samples were allowed to clot at room temperature for up to 2 h
before centrifuging at 9224 3 g for 10 min at room temperature. The
separated serum was collected into Eppendorf tubes and stored at
280C until analysis.
Analyses
A brief summary of the analyses is given below with more details in the
Supplemental Materials and Methods.
Fatty lesions (atherosclerotic plaques). The whole aortas collected
from Study 1 mice were quantified for fatty lesions after fixation with
paraformaldehyde and staining with Sudan IV. Digital images were
collected of the stained aortas, and these were assessed and quantified for
the degree of red staining. The mean data of the 7–10 aortas per group
are given for each dietary silicon group. Staining and image analysis were
carried out in a blinded fashion.
Biomechanic properties of the aorta. The descending aortas collected
from Study 2mice were each segmented into seven 2-mm aortic rings and
each underwent biomechanic testing to determine elasticity (or stiffness)
and the forces required to rupture the aortic specimen (Supplemental
Figures 2 and 3). A sensitive tensile testing setup was constructed for
these analyses (M Stoiber, H Schima, unpublished results, 2013). Values
are reported for each of the 7 individual 2-mm rings. Again, analysis was
conducted in a blinded fashion.
Elastin and collagen contents. Total elastin and collagen contents
were determined for the aortas collected in Study 2. The descending
aortas were air-dried and homogenized, and elastin and collagen were
extracted and quantified with use of the Fastin Elastin Assay kit and
hydroxyproline assay (22), respectively. Elastin and collagen contents
were expressed as gram per gram dry weight of sample. It was assumed
aortic collagen contains a mean of 13.5% w/w hydroxyproline (23, 24).
Histochemical analysis of the elastic fibers. The quality of the elastic
fibers of the aorta of mice from the 3 dietary silicon groups was
examined. The abdominal aorta, aortic arch, and iliac bifurcation
(Supplemental Figure 1) from mice in Study 2 were fixed with formalin
and embedded in paraffin wax. Four-micrometer thickness sections were
stained for the elastic fibers, digitally imaged, and viewed by a pathologist
in a blinded fashion.
Serum lipids. Total, HDL, and LDL cholesterol as well as TG
concentrations in the terminal serum sample were compared between
the 3 dietary silicon groups. Serum samples from (feed-deprived) mice at
baseline (before separation into the experimental groups) were similarly
analyzed; however, because of the small numbers (n = 3), the baseline
samples were not compared statistically with the treatment groups.
Analysis was conducted with a serum chemistry analyzer (Siemens
Healthcare AG) in a blinded fashion, and concentrations are given in
mmol/L.
Total elemental analysis. The total silicon concentration in serum
from mice in the 3 dietary silicon groups was measured by inductively
coupled plasma optical emission spectroscopy, as previously described
(25, 26), with use of appropriate sample-based standards. Feed and
drinking water samples were also analyzed for total silicon with appro-
priate standards.
Statistical analysis
Results are expressed as means 6 SDs, unless otherwise stated. All 3
dietary silicon groups were compared with each other. One-factor
ANOVAwas used to compare means for feed intake, water intake, serum
lipid concentrations, deposition of fatty lesions, aortic circumference,
aortic collagen concentration, and aortic elastin concentration. Signif-
icant difference was taken as P < 0.05. The independent samples
Kruskal-Wallis test with pairwise comparison was used to assess the
means for silicon intake, total serum silicon concentration, and aorta
silicon concentration because these data were not normally distributed.
Significance was taken as P < 0.05. Repeated-measures ANOVA was
used to assess body weight over the study period and biomechanic
measures (i.e., maximum tear force, elasticity, and circumference) along
the 7 aortic positions, with significant group differences taken as P <
0.05. Bonferroni post hoc analysis was used to determine the significant
differences in maximum tear force. All statistical analysis was conducted
in IBM SPSS Statistic 22 for Windows.
Results
Silicon intake. There was no difference in feed and water
intakes between the 3 dietary silicon groups in both studies
(Supplemental Table 2). In Study 1, silicon intakes in the 2Si
group were 98.1% lower than the +Si-feed group (P < 0.001)
and 94.7% lower than the +Si-water group, although this
difference was not significant (P = 0.07). Overall, feed intakes
were lower for the mice in Study 2 than Study 1 but, still, the2Si
group had 98.5% lower silicon intake than the +Si-feed group
(P < 0.001) and 97.5% lower intake than the +Si-water group
(P = 0.007). Silicon intakes did not differ between the +Si groups
in both studies.
Body and tissue weights. Silicon deprivation had no effect
on body mass (Figure 1) or the wet mass of the tissues and
organs collected at necropsy (Supplemental Figure 4); both were
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comparable between the 3 dietary silicon groups. Equally, there
was no difference in outward appearance of the mice over the
study period, although some mice in all groups suffered from
some hair loss caused by overgrooming, which is common in this
strain of mouse.
Serum and aorta silicon concentrations. In Study 1, mean
serum silicon concentration in the 2Si group was 78% lower
than the +Si-feed group (P = 0.003) and 84% lower than the +Si-
water group (P < 0.001) (Figure 2A). Similarly in Study 2, mean
serum silicon concentration in the 2Si group was 60% lower
than the +Si-feed group (P < 0.001) and 52% lower than the +Si-
water group (P = 0.006) (Figure 2B). There was no difference in
serum silicon concentration between the +Si groups.
Silicon concentration of the whole aorta collected in Study
1 was 65% lower in the 2Si group than the +Si-feed group (P =
0.025), but was not different compared to the +Si-water group
(Figure 3). Again, there was no difference in (aortic) silicon
concentration between the +Si groups.
Fatty lesions (atherosclerotic plaques). The whole aortas
from the mice in Study 1 were stained for fatty lesions (early
development of atheromatous plaques) on the luminal surface
(Figure 4A). However, there was no difference in percentage
coverage of the whole aorta (Figure 4B) or the aortic arch (Figure
4C) by fatty lesions between the 3 dietary silicon groups.
Serum lipids. Hemolysis in the serum samples (caused by an
accident during processing of the blood) of the 2Si group in
Study 1 interfered with the lipid analysis of these samples, so
comparison with the +Si groups could not be made. However,
comparison of serum lipid concentrations (i.e., TGs, total
cholesterol, HDL cholesterol, and LDL cholesterol) of the
terminal blood samples collected in Study 2 could be made and
showed no significant difference between the 3 dietary silicon
groups (Table 1).
Biomechanic tests. From the tensile measurements in Study 2,
the forces required to rupture the aortic wall were determined
for the different dietary silicon groups. Maximum tear force
increased when moving down the descending aorta, peaking at
position 5 or 6 with a reduction at position 7 (Figure 5A). The
pattern was comparable between the 2Si and +Si-feed groups,
but a significant difference was found between 2Si and +Si-
water groups (P = 0.010), suggesting less force was required to
FIGURE 1 Body weights of female apoE knockout mice in Study
1 (A) and Study 2 (B) fed a diet high in butter fat and depleted in silicon,
compared with mice fed the 2 silicon-replete, high-fat diets: silicon
was replete in the feed or the drinking water. Values are means 6
SDs; n = 7–10 for Study 1, and n = 10–15 for Study 2. Mice were
deprived of food overnight before measurement of body weight.
There were no differences in body weight between the 3 dietary
silicon groups in both studies. 2Si, silicon-deprived; +Si-feed, silicon-
replete in feed; +Si-water, silicon-replete in drinking water.
FIGURE 2 Total silicon concentration in the serum of female apoE
knockout mice in Study 1 (A) and Study 2 (B) fed a diet high in butter fat
and depleted in silicon, compared with mice fed the 2 silicon-replete,
high-fat diets: silicon was replete in the feed or the drinking water.
Values (n = 7–10/group for Study 1, and n = 10–15/group for Study 2)
are shown as box-plots where the horizontal lines indicate the 5th,
25th, 50th (i.e., median), 75th, and 95th percentiles, the open squares
show the means, and the crosses show the minimum and maximum
values. Mice were deprived of food overnight before collection of
serum. Within each graph, labeled groups without a common letter
differ (P, 0.05; independent samples Kruskal-Wallis test with pairwise
comparison). Si, silicon; 2Si, silicon-deprived; +Si-feed, silicon-replete
in feed; +Si-water, silicon-replete in drinking water.
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rupture the aortic wall in the +Si-water group. There was no
difference in maximum tear force between +Si groups.
A higher slope was found moving down the descending aorta
from position 1 to position 7, i.e., away from the aortic arch
and heart (Figure 5B), suggesting that the aorta is less flexible
as it moves away from the heart. This pattern did not differ
significantly between the 3 dietary silicon groups.
Initial ring circumference at the 7 positions along the aorta
was found to decrease from position 1 to position 5 and level off
thereafter (Figure 5C). A comparable pattern was seen for the 3
dietary silicon groups. Averaging the circumference at the 7
positions also did not show any significant difference between
the 3 dietary silicon groups, even at higher aortic pressures
(Supplemental Table 3).
Elastic structure and morphology. Histochemical staining
and pathologic analysis of the aortic arch, abdominal aorta, and
iliac bifurcation from the aortas collected in Study 2 showed no
difference in the structure, size, or number of the elastic fibers
between the 3 dietary silicon groups (Supplemental Figure 5).
Collagen and elastin contents. Analysis of the descending
aortas collected in Study 2 for total elastin and collagen contents
found no difference in mean aortic contents between the 3
dietary silicon groups (Figure 6).
Discussion
This study aimed to investigate themechanism of action of dietary
silicon on vascular (aortic) health using a mouse model of
atherosclerosis. Overall, we found that dietary silicon deprivation
had no effect on the development of fatty lesions or on serum lipid
concentrations. Dietary silicon deprivation also had no effect on
the elastin and collagen contents of the aorta wall, morphology of
the elastin fibers, or the biomechanic properties of the aorta.
The lack of effect of dietary silicon on the development of
fatty lesions is contrary to the findings of others including
Loeper et al. (8, 9), who reported that dietary silicon supple-
mentation significantly reduced, and almost negated, the
formation of atheromatous plaques in a cholesterol-fed rabbit
model. This disparity in findings may be explained by the
severity of the model used herein. The apoE knockout mouse
model used here is a well-established genetic model of athero-
FIGURE 3 Total silicon concentration of the aorta of female apoE
knockout mice in Study 1 fed a diet high in butter fat and depleted in
silicon, compared with mice fed the 2 silicon-replete, high-fat diets:
silicon was replete in the feed or the drinking water. Values (n = 6–10/
group) are shown as box-plots where the horizontal lines indicate the
5th, 25th, 50th (i.e., median), 75th, and 95th percentiles, the open
squares show the means, and the crosses show the minimum and
maximum values. Mice were deprived of food overnight before
collection of aorta. Within the graph, labeled groups without a common
letter differ (P , 0.05; independent samples Kruskal-Wallis test with
pairwise comparison). Si, silicon;2Si, silicon-deprived; +Si-feed, silicon-
replete in feed; +Si-water, silicon-replete in drinking water.
FIGURE 4 Quantification of fatty lesions in the whole aorta of
female apoE knockout mice in Study 1 fed a diet high in butter fat and
depleted in silicon, compared with mice fed the 2 silicon-replete, high-
fat diets: silicon was replete in the feed or the drinking water. (A)
Digital images showing staining of fatty lesions on the luminal surface;
one example from each dietary silicon group. Quantification of the
whole aortic area occupied by fatty lesions (B) or just at the aortic arch
(C), as a percentage of the total area of the aorta quantified. Values
(n = 7–10/group) are shown as box-plots where the horizontal lines
indicate the 5th, 25th, 50th (i.e., median), 75th, and 95th percentiles,
the open squares show the means, and the crosses show the
minimum and maximum values. There was no difference between the
3 dietary silicon groups. 2Si, silicon-deprived; +Si-feed, silicon-replete
in feed; +Si-water, silicon-replete in drinking water.
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sclerosis (27, 28), but it is a more severe mouse model than others
that exist (29, 30). Notably, the complete lack of lipoprotein
clearance in the apoE mice affects other anti-inflammatory and
immunomodulatory properties, and these mice also develop
diabetes and Alzheimers dementia (27, 29, 30). The apoE mice
also appear to show a lack of sensitivity toward statins, the
standard therapy for patients with atherosclerosis (27, 28,
31–35). The other mouse models (lipoprotein lipase knockout
and LDL receptor knockout) are less severe and more specifi-
cally target the cardiovascular system (29, 30), but again, these
also show differences in sensitivities toward statins and thus do
not completely mimic the human condition. The cholesterol-fed
rabbit model used by Loeper et al. (8, 9) and others is a much less
severe model as judged by the more modest increase in total
serum cholesterol/lipids that is observed (7–9). However, even
with the limitation described above, the apoE knockout mouse
model has been used to investigate the effect of nutritional
components on atherosclerosis development, and a reduction in
plaque area has been reported for a number of nutrients (36–40).
A marked reduction in the plasma total cholesterol concentra-
tion was additionally reported by Xia et al. (39) and Mori et al.
(40). These studies (36–40) were conducted in male apoE
knockout mice $6 wk of age, and the mechanism of action of
3 of the compounds (36–39) is described as being related to their
anti-inflammatory activities. Other nutrients/nutritional factors
have also been tested in the apoE knockout mouse model and
shown to be antiatherosclerotic, again related to their anti-
inflammatory or antioxidant activities (41–46). Although one
study reported that dietary silicon exposure may influence the
immune/inflammatory response (47), the lack of activity here
may imply that dietary silicon has no direct anti-inflammatory or
antioxidant properties in the apoE knockout mouse model.
However, this study was not designed to specifically investigate
the anti-inflammatory properties of dietary silicon. CLA, present
in dairy products including butter [CLA constitutes ;0.44% of
total FAs (48)], may have masked any small effect of silicon on
inflammation. Milk (butter) fat was used here because it
accelerates atherosclerosis development, is more potent than
other sources of fats (49), and has been used previously in the
apoE knockout mouse model [e.g., Buus et al. (37)]. Female
(apoE) mice were used here because our previous studies suggest
females of the species are more sensitive to dietary silicon
exposure (17, 18).
One of the proposed mechanisms of action of dietary silicon
is that it may decrease the concentrations of FAs in serum and
aorta that are negatively linked to atherosclerotic plaque
formation (7–9, 16). Loeper et al. (9) reported a 13% drop in
total serum lipids, a 15% drop in total serum cholesterol, and a
20% drop in aorta lipid concentration with silicon supplemen-
tation (monomethylsilanetriol) in rabbits. Loeper et al. (9) also
studied FFAs and total FAs and esters in serum and the aorta and
concluded that silicon reduced MUFAs and PUFAs, in particular
arachidonic acid, which is involved in lipid peroxidation. Trinca
et al. (7) similarly reported a drop in serum cholesterol (by
44%), total lipids (44%), HDL cholesterol (18%), FFAs (31%),
TGs (29%), and phospholipids (26%) with silicon supplemen-
tation (sodium silicate) in rabbits. Najda et al. (16), however,
reported no change in total serum cholesterol, an increase in
serum HDL cholesterol (20%) and serum HDL phospholipids
(30%), and a drop in serum LDL cholesterol (23%), serum TGs
(30%), and aorta cholesterol concentration (20%) with silicon
supplementation (sodium metasilicate) in male Wistar rats.
These findings suggest that the antiatherosclerotic effects of
silicon may be partly dependent on a reduction in serum lipids
(16). In our study, no significant difference in serum lipid
concentrations was found between the dietary silicon groups
(Table 1). Thus, overall we conclude that, in the apoE mouse
model, silicon deprivation had no adverse effect on total serum
cholesterol and thus no effect on aortic lesions. It should be
pointed out that the 2 apoE mouse studies that reported both a
marked reduction in plasma total cholesterol and a reduction in
aortic fatty lesions used a normal diet containing 5–7% fat and
<0.07% cholesterol (39, 40). The diet used here had a higher
fat content (21% wt milk fat) and a higher concentration
of cholesterol (1.5% wt).
It has also been suggested that silicon is an important
structural component of the aortic wall that protects the vessel
against lipid permeability and the development of fatty lesions.
Collagen and elastin are 2 of the major components of the aortic
wall that determine its biomechanic properties and functional
integrity, and in atherosclerosis these are broken down (38, 50).
Silicon may bind to these components to increase their stability
or it may increase the synthesis and contents of these compo-
nents in the aortic wall (10). Indeed, Loeper et al. (8) reported
that the elastic fibers seemed ‘‘undamaged and often thickened’’
in the silicon-supplemented group in the cholesterol-fed rabbit
model. Additionally, statins have been suggested to increase the
collagen content of the aorta to stabilize the plaques and reduce
their rupture (30). Here, we investigated whether silicon
deprivation could alter the composition of collagen and elastin
in the aortic wall and thereby decrease the stability of the aorta.
Silicon deprivation had no effect on total elastin and collagen
TABLE 1 Terminal serum lipid concentrations of female apoE knockout mice fed a diet high in butter fat
and depleted in silicon for 19 wk, compared with mice fed the 2 silicon-replete, high-fat diets (Study 2)1
Baseline2 (n = 3)
Experimental groups
P 52Si (n = 15)3 +Si-feed (n = 9)4 +Si-water (n = 10)
TGs, mmol/L 0.65 6 0.06 0.85 6 0.17 0.95 6 0.15 0.99 6 0.25 0.17
Total cholesterol, mmol/L 4.87 6 0.44 8.33 6 1.33 7.09 6 0.96 7.76 6 1.76 0.12
HDL cholesterol, mmol/L 3.00 6 0.21 4.32 6 0.56 3.88 6 0.92 3.98 6 1.21 0.66
LDL cholesterol, mmol/L 1.58 6 0.56 2.67 6 0.63 2.69 6 0.55 2.86 6 0.88 0.85
1 Values are means 6 SDs; n = 3–15 mice/group. Mice were deprived of food overnight before collection of serum. 2Si, silicon-deprived
(,3-mg silicon/g); +Si-feed, silicon-replete in feed (100-mg silicon/g); +Si-water, silicon-replete in drinking water (115-mg silicon/mL).
2 Female apoE knockout mice before separation into experimental groups and administration of high-fat diet. Baseline samples were not
statistically compared to treatment groups.
3 Except HDL cholesterol and LDL cholesterol where n = 7.
4 Except HDL cholesterol and LDL cholesterol where n = 8.
5 One-factor ANOVA comparison of the experimental groups.
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contents or morphology of the elastic fibers. Macroscopically,
the elastic fibers in all the groups looked ‘‘normal,’’ suggesting
that the aortas were not markedly damaged in our studies.
Santelices et al. (51) showed that damage to the aorta in apoE
mice is slow but progressive until between 25 and 34 wk of age
when a marked increase in damage to the aortic wall is observed.
The apparent lack of difference in composition of the aortic
wall between the 3 different dietary silicon groups is further
confirmed by the similarities in the biomechanic properties of
the aorta.
It is possible that, although serum silicon concentrations were
lower in the2Si group, than in the +Si groups, the mice may not
have been deficient in silicon. Indeed, the lack of significant
difference in aortic silicon concentrations between the 2Si and
+Si-water groups would imply this to be the case, and this could
explain the lack of difference in structural and biomechanic
properties of the aortas between the dietary silicon groups. We
previously reported that female Sprague Dawley rats on a 2Si
diet actively maintained their tissue silicon concentrations by
reducing/inhibiting urinary silicon output (3), and so the same
could have occurred in the mice in this study.
In conclusion, we found that dietary silicon deprivation had
no effect on the development of atheromatous lesions in the
apoE knockout mouse model. This is contrary to the reported
findings in the cholesterol-fed rabbit model and the positive
effects of dietary silicon supplementation on vascular health
reported by others. Further work, in a dietary-based rather than
‘‘genetically programmed’’ model of atherosclerosis, is now
needed to corroborate these findings.
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